{"url":"https://lda.senate.gov/api/v1/filings/cfb08ba6-4b61-4c8d-9217-ecc51d728baf/","filing_uuid":"cfb08ba6-4b61-4c8d-9217-ecc51d728baf","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2025,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/cfb08ba6-4b61-4c8d-9217-ecc51d728baf/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Alisa Jane Hess","dt_posted":"2025-07-19T10:19:44-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 North Capitol Street, NW","registrant_address_2":"Suite 210","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":1171,"url":"https://lda.senate.gov/api/v1/registrants/1171/","house_registrant_id":31749,"name":"ALPINE GROUP PARTNERS, LLC.","description":"Public relations consulting firm","address_1":"500 North Capitol Street, NW","address_2":"Suite 210","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISA JANE HESS","contact_telephone":"+1 434-933-2535","dt_updated":"2026-07-23T13:44:46.970916-04:00"},"client":{"id":102125,"url":"https://lda.senate.gov/api/v1/clients/102125/","client_id":1005813,"name":"MALLINCKRODT","general_description":"Specialty Pharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"MO","state_display":"Missouri","country":"US","country_display":"United States of America","ppb_state":"MO","ppb_state_display":"Missouri","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-05-25"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Reauthorization of the Pandemic All Hazards Preparedness Act, industrial base expansion Legislation related to drug pricing, drug price transparency and PBMS Implementation of the IRA, drug pricing provisions Legislation related to supply chains associated with active pharmaceutical ingredients and pharmaceuticals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":93714,"prefix":null,"prefix_display":null,"first_name":"KEENAN","nickname":null,"middle_name":null,"last_name":"AUSTIN REED","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to the drug supply chains","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":93714,"prefix":null,"prefix_display":null,"first_name":"KEENAN","nickname":null,"middle_name":null,"last_name":"AUSTIN REED","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax incentives for the onshoring of APIs and essential medicines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":93714,"prefix":null,"prefix_display":null,"first_name":"KEENAN","nickname":null,"middle_name":null,"last_name":"AUSTIN REED","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}